XBRANE BIOPHARMA AB financial statements, including revenue, expenses, profit, and loss
The total revenue of XBRANE for the last quarter is 66.89 M SEK, and it's 13.59% higher compared to the previous quarter. The net income of Q4 23 is -157.53 M SEK.